CanMED: NDC

Drug Name (Brand or Generic) Separate terms with OR to return results that match either term.

Major Class

Package in use from (mm/dd/yyyy):

To:

SEER*Rx Category

Clear All

10,000 Matching Results — Export these results

Click column titles once to sort ascending, and twice to sort descending.

Show Entries

NDC-11 (Package)	NDC-9 (Product)	Generic Name	Brand Name	Strength	SEER*Rx Category	Major Class	Minor Class	Administration Route	Package Effective Date	Status
53217-0300-60	53217-0300	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 25, 2007	In Use
54569-6124-00	54569-6124	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	May 9, 2016	In Use
54569-6124-01	54569-6124	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	May 9, 2016	In Use
54569-6124-02	54569-6124	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	May 9, 2016	In Use
54569-6208-00	54569-6208	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	May 10, 2016	In Use
54569-6208-01	54569-6208	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	May 10, 2016	In Use
54569-6208-02	54569-6208	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	May 10, 2016	In Use
54868-5749-00	54868-5749	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Jan. 16, 2007	In Use
54868-5749-01	54868-5749	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Jan. 16, 2007	In Use
54868-5887-00	54868-5887	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	May 8, 2008	In Use
54868-5887-01	54868-5887	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	May 8, 2008	In Use
54868-5888-00	54868-5888	Ondansetron	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intravenous	May 8, 2008	In Use
55045-3848-09	55045-3848	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 27, 2007	In Use
55154-3680-00	55154-3680	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 27, 2007	In Use
55154-3683-00	55154-3683	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 27, 2007	In Use
55154-5369-00	55154-5369	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Dec. 5, 2012	In Use
55154-5431-00	55154-5431	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 31, 2007	In Use
57237-0077-10	57237-0077	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 12, 2010	In Use
57237-0077-30	57237-0077	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 12, 2010	In Use
57237-0078-10	57237-0078	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 12, 2010	In Use
57237-0078-30	57237-0078	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 12, 2010	In Use
57881-0444-01	57881-0444	Ondansetron	Zuplenz	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Oct. 8, 2014	In Use
57881-0444-10	57881-0444	Ondansetron	Zuplenz	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Oct. 8, 2014	In Use
57881-0448-01	57881-0448	Ondansetron	Zuplenz	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Oct. 8, 2014	In Use
57881-0448-10	57881-0448	Ondansetron	Zuplenz	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Oct. 8, 2014	In Use
60760-0305-10	60760-0305	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	May 23, 2014	In Use
60760-0306-10	60760-0306	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 1, 2016	In Use
61919-0218-10	61919-0218	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Jan. 1, 2014	In Use
62756-0240-64	62756-0240	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 2, 2007	In Use
62756-0240-83	62756-0240	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 2, 2007	In Use
62756-0356-64	62756-0356	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 2, 2007	In Use
62756-0356-66	62756-0356	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 2, 2007	In Use
62756-0356-83	62756-0356	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 2, 2007	In Use
63629-5073-01	63629-5073	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 25, 2007	In Use
63629-5073-02	63629-5073	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 25, 2007	In Use
65293-0374-01	65293-0374	Ondansetron	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	Nov. 18, 2009	In Use
65293-0374-20	65293-0374	Ondansetron	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	Nov. 18, 2009	In Use
65862-0390-10	65862-0390	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 12, 2010	In Use
65862-0390-19	65862-0390	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 12, 2010	In Use
65862-0390-30	65862-0390	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 12, 2010	In Use
68462-0157-13	68462-0157	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 27, 2007	In Use
68462-0158-11	68462-0158	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 27, 2007	In Use
68462-0158-13	68462-0158	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 27, 2007	In Use
68788-9559-01	68788-9559	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 27, 2013	In Use
68788-9559-03	68788-9559	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 27, 2013	In Use
68788-9559-05	68788-9559	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 27, 2013	In Use
68788-9670-01	68788-9670	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 24, 2013	In Use
68788-9670-03	68788-9670	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 24, 2013	In Use
68788-9670-05	68788-9670	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 24, 2013	In Use
50436-0187-01	50436-0187	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 4, 2016	In Use

Found 10,000 results in 6 milliseconds — Export these results

CanMED and the Oncology Toolbox

CanMED: NDC